BRIEF published on 09/11/2025 at 06:35, 4 months 24 days ago Siegfried Successfully Raises CHF 300 Million through Bond Placement SIX Swiss Exchange Bond Placement Siegfried AG CH 300 Million Pharmaceutical CDMO
PRESS RELEASE published on 09/11/2025 at 06:30, 4 months 24 days ago Siegfried successfully places senior bonds of CHF 300 million Siegfried successfully places CHF 300 million senior bonds with a 1.3% coupon for general corporate purposes, including early refinancing. Bonds to be listed on SIX Swiss Exchange SIX Swiss Exchange Bonds Siegfried CHF 300 Million CDMO Industry
BRIEF published on 08/21/2025 at 06:35, 5 months 15 days ago Siegfried AG Reports Continued Profitable Growth in H1 2025 Financial Results Profitable Growth Infrastructure Expansion 2025 Outlook EVOLVE+ Strategy
PRESS RELEASE published on 08/21/2025 at 06:30, 5 months 15 days ago Siegfried on track to deliver profitable growth Siegfried achieves profitable growth in H1 2025, with a focus on strategy execution and operational excellence. Net sales up 1.6%, Core EBITDA margin at 21.6%, and outlook confirmed Operational Excellence Profitable Growth Strategy Execution Siegfried H1 2025
BRIEF published on 07/17/2025 at 06:35, 6 months 19 days ago Change in Siegfried's Executive Committee Executive Committee Siegfried AG DINAMIQS Peter Freisler Marianne Späne
PRESS RELEASE published on 07/17/2025 at 06:30, 6 months 19 days ago Change in Siegfried's Executive Committee Siegfried announces change in Executive Committee with Peter Freisler as Chief Business Officer effective August 1, 2025, succeeding Marianne Späne. Späne to focus on non-executive roles and join DINAMIQS Board as of 2026 Executive Committee Siegfried DINAMIQS Peter Freisler Marianne Späne
BRIEF published on 05/23/2025 at 06:35, 8 months 13 days ago Siegfried Expands Ophthalmic Drug Production in Spain Production Capacity Pharmaceutical Manufacturing Siegfried AG Ophthalmic Drugs El Masnou
PRESS RELEASE published on 05/23/2025 at 06:30, 8 months 13 days ago Siegfried expands production capacity for ophthalmic drugs in El Masnou Siegfried announces further expansion of ophthalmic drug manufacturing site in El Masnou, Spain, to meet growing customer demand. New capacity to be available by 2027 Expansion Manufacturing Siegfried Ophthalmic Drugs El Masnou
BRIEF published on 04/10/2025 at 15:35, 9 months 24 days ago Siegfried Shareholders Endorse Proposals at 2025 AGM Financial Statements Capital Reduction Share Split Shareholder Proposals Siegfried AGM 2025
PRESS RELEASE published on 04/10/2025 at 15:30, 9 months 24 days ago Siegfried shareholders approve all proposals at Annual General Meeting 2025 Siegfried Holding AG shareholders approve key proposals at 122nd Annual General Meeting 2025, including capital reduction and share split. Chairman confirms limited exposure to US tariffs Annual General Meeting Shareholders Capital Reduction Share Split Siegfried Holding AG
Published on 02/05/2026 at 12:00, 27 minutes ago Datavault AI Chief Executive Officer and President Issues Letter to Stockholders Highlighting 2025 Accomplishments and Outlook for 2026
Published on 02/05/2026 at 09:05, 3 hours 22 minutes ago BioNxt Secures Innovative Chaperone Technology to Enhance Oral Thin-Film Drug Delivery
Published on 02/05/2026 at 01:35, 10 hours 52 minutes ago Dr. Ruben Shiffman Files Early Warning Report in Respect of Greenland Resources
Published on 02/05/2026 at 00:00, 12 hours 27 minutes ago Onco-Innovations Announces Filing of Preliminary Base Shelf Prospectus
Published on 02/04/2026 at 22:25, 14 hours 2 minutes ago 55 North Mining Announces Flow-Through Financing
Published on 02/05/2026 at 11:47, 40 minutes ago Worthington Steel Announces Start of Acceptance Period for All-Cash Tender Offer of €11.00 per Share to Shareholders of Kloeckner & Co SE
Published on 02/05/2026 at 11:45, 42 minutes ago EQS-WpÜG: Takeover Offer / Target company: Klöckner & Co SE; Bidder: Worthington Steel GmbH
Published on 02/05/2026 at 11:30, 57 minutes ago Linde Reports Full-Year and Fourth-Quarter 2025 Results (Earnings Release Tables Attached)
Published on 02/05/2026 at 11:30, 57 minutes ago Disclosure of shares outstanding and voting rights - 05.02.2026
Published on 02/04/2026 at 18:04, 18 hours 23 minutes ago Total number of voting rights and shares making up the share capital at January 31, 2026
Published on 02/04/2026 at 17:45, 18 hours 42 minutes ago Information concerning the total number of voting rights and shares 2026 01 31
Published on 02/04/2026 at 17:45, 18 hours 42 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
